New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

VHTvsIHEETF Comparison

ETF 1
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
-0.76%
VS
ETF 2
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
-0.76%

Vanguard Health Care ETF (VHT) and iShares U.S. Pharmaceuticals ETF (IHE) belong to the same industry segment: US Health Care. VHT's top 3 sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. In contrast, IHE's top sector exposures are Healthcare and Non-Corporate. VHT is less expensive with a Total Expense Ratio (TER) of 0.09%, versus 0.37% for IHE. VHT is up 8.91% year-to-date (YTD) with +$89M in YTD flows. IHE performs better with 20.21% YTD performance, and +$599M in YTD flows. Run a side-by-side ETF comparison of VHT and IHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

VHT vs IHE performance and flow charts

Performance

-2.0-1.00.01.02.03.04.0%Aug 10Aug 17Aug 24Aug 31Sep 8

Cumulative Flows

0 M20 M40 M60 M80 MAug 10Aug 17Aug 24Aug 31Sep 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/10/2026
1M3MYTD1Y3Y5Y
Perf.
VHT
IHE
-1.78%-2.49%
+9.90%+8.87%
+8.91%+20.21%
+23.87%+44.96%
+33.75%+67.41%
+29.38%+74.30%
Flows
VHT
IHE
+$73M+$22M
+$372M+$607M
+$89M+$599M
+$324M+$756M
-$2.17B+$848M
-$965M+$853M
Volatility and drawdown
3M1Y3Y5Y
Volatility
VHT
IHE
+18.20%+20.04%
+15.74%+18.30%
+14.66%+17.02%
+15.57%+16.58%
Max drawdown
VHT
IHE
-5.54%-6.32%
-10.39%-8.48%
-16.88%-16.04%
-17.77%-16.12%
Max drawdown duration
VHT
IHE
22d22d
169d81d
435d210d
767d669d
Trading data

Create an account to view trading data

Join for free
VHT
IHE
Last sale
9/11/2026 at 1:30 PM
$310.83
$101.10
Previous close
09/10/2026
$311.27
$101.27
Consolidated volume
09/10/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
VHT
IHE
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
VHT
IHE
Last price
$310.83
$101.10
1D performance
-0.14%
-0.17%
AuM$18.81 B$1.62 B
E/R0.09%0.37%
Characteristics
VHT
IHE
Management strategyPassivePassive
ProviderVanguardiShares
BenchmarkMSCI US IMI Health Care 25/50 IndexDow Jones U.S. Select Pharmaceuticals Index
N° of holdings41357
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2004May 1, 2006
ESGNoNo
Advertisement
Exposure

Countries

VHT
USA
96.91%
Other
3.09%
IHE
USA
95.81%
Other
4.19%

Sectors

VHT
Healthcare
97.52%
Other
2.48%
IHE
Healthcare
99.62%
Other
0.38%
Advertisement

Diversification

VHT

Total weight of top 15 holdings out of 15

61.16%
IHE

Total weight of top 15 holdings out of 15

84.32%

Top 15 holdings

Data as of July 31, 2026
VHT
Eli Lilly & Co.
13.37%
Johnson & Johnson
8.83%
AbbVie, Inc.
6.43%
UnitedHealth Group, Inc.
5.45%
Merck & Co., Inc.
4.67%
Thermo Fisher Scientific, Inc.
3.09%
Amgen, Inc.
3.01%
Abbott Laboratories
2.67%
Gilead Sciences, Inc.
2.34%
Pfizer Inc.
2.06%
Bristol Myers Squibb Co.
1.93%
CVS Health Corp.
1.93%
Intuitive Surgical, Inc.
1.82%
Danaher Corp.
1.80%
Vertex Pharmaceuticals, Inc.
1.76%
IHE
Johnson & Johnson
21.85%
Eli Lilly & Co.
20.71%
Bristol Myers Squibb Co.
4.75%
Viatris, Inc.
4.56%
Merck & Co., Inc.
4.44%
Royalty Pharma Plc
4.41%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.81%
Jazz Pharmaceuticals Plc
3.58%
Elanco Animal Health, Inc.
2.92%
Corcept Therapeutics, Inc.
2.49%
Axsome Therapeutics, Inc.
2.24%
Crinetics Pharmaceuticals, Inc.
1.95%
Liquidia Corp.
1.35%
Ligand Pharmaceuticals, Inc.
1.31%
Frequently asked questions about VHT and IHE

How have the VHT and IHE ETFs performed in 2026?

As of September 10, 2026, VHT is up 8.91% year-to-date (YTD), while IHE has returned 20.21%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: VHT or IHE?

Year-to-date, the VHT ETF saw +$89M in flows, compared to +$599M for IHE.

Which ETF is more volatile: VHT or IHE?

Over the past year, VHT had a volatility of 15.74%, while IHE experienced 18.3%.

Which ETF is bigger: VHT or IHE?

As of September 10, 2026, VHT holds $18.81 B in assets under management (AUM), while IHE manages $1.62 B.

What sectors do the VHT and IHE ETFs invest in?

VHT leans toward sectors like Healthcare. Meanwhile, IHE focuses on Healthcare.

What are the top holdings of the VHT ETF and IHE ETF?

VHT top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. IHE holds in its top three: Johnson & Johnson, Eli Lilly & Co. and Bristol Myers Squibb Co..

Which ETF is more diversified: VHT or IHE?

VHT holds 413 securities with 61.16% of its assets in the top 15. IHE has 57 securities and a top 15 weight of 84.32%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR TOOLS

Build and Analyze Your ETF Portfolio Like a Pro

Create your own ETF portfolio in minutes and instantly see allocations, exposures, performance, and risk. Visualize diversification across asset classes, regions, and sectors. Stress-test ideas, compare benchmarks, and refine your strategy with professional-grade analytics.

Portfolio Builder